AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sukinsa 25mg Capsule

Prescription Icon
Prescription Required

Marketer

Halsted Pharma Private Limited

Salt Composition

Sunitinib (25mg)

Overview Sukinsa 25mg Capsule

Oncaspar 25mg capsules treat kidney cancer and gastrointestinal stromal tumors by inhibiting enzymes crucial for cancer cell proliferation. This action reduces tumor size and growth rate. While Oncaspar 25mg capsules can be ingested with or without food, consistent daily timing maximizes efficacy. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Strictly adhere to your doctor's instructions; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinue only under medical guidance. Common side effects encompass fatigue, diarrhea, nausea, vomiting, altered taste perception, and reduced appetite. Regular blood pressure and thyroid function monitoring may be recommended. Hypoglycemia, potentially severe enough to cause fainting, is possible; diabetics should monitor blood glucose frequently and consult their physician regarding anti-diabetic medication adjustments. Prior to commencing treatment, inform your doctor of any heart, liver, kidney, or bleeding disorders. Inform your healthcare provider of all other medications being taken, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is essential for both partners throughout treatment.

Uses of Sukinsa 25mg Capsule

Managing renal cell carcinoma and gastrointestinal stromal tumors.

Major Benefits of Sukinsa 25mg Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for Sukinsa 25mg Capsules. These capsules can be ingested with or without food, although consistent timing is recommended.

Common Side effects of Sukinsa 25mg Capsule:

  • Hand-foot syndrome
  • Bleeding disorder
  • Low blood platelets
  • Decreased appetite
  • Nausea
  • Vomiting
  • Weakness
  • Abdominal pain
  • Indigestion
  • High blood pressure
  • Diarrhea
  • Stomatitis (Inflammation of the mouth)
  • Taste change

How to use Sukinsa 25mg Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for Sukinsa 25mg Capsules. These capsules can be administered with or without food, although consistent timing is recommended.

How Sukinsa 25mg Capsule works:

Sukinsa 25mg capsules are an anticancer agent. Their mechanism involves targeting and inhibiting specific cell-surface tyrosine kinases, proteins crucial for cancer cell division. Concurrently, they suppress angiogenesis, the formation of new blood vessels supplying the tumor, thereby hindering malignant tumor growth.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The interaction between Sukinsa 25mg Capsule and alcohol is undetermined. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sukinsa 25mg Capsules during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the potential advantages against any possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sukinsa 25mg Capsules while breastfeeding is likely inadvisable. Available human data indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by Sukinsa 25mg Capsules, which can induce dizziness. Refrain from driving or operating machinery if dizziness occurs during treatment.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney disease can safely use Sukinsa 25mg Capsules without requiring any dosage modification.

LiverLiverSAFE IF PRESCRIBED

Liver impairment does not necessitate altered dosing of the 25mg Sukinsa capsule; its use remains safe in such patients.

What if you forget to take Sukinsa 25mg Capsule :

Omit any missed Sukinsa 25mg Capsule dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Sukinsa 25mg Capsule

LabelValue
Chemical Category Indole and Pyrrole Derivatives
Developing Habits No.
Type of Therapy Cancer Medications

FAQs on Sukinsa 25mg Capsule

Follow your doctor's instructions precisely when taking Sukinsa 25mg Capsules. This medication should only be initiated by oncologists experienced in cancer treatment. Take one capsule daily, with or without food. Avoid grapefruit juice and grapefruit while using Sukinsa 25mg Capsules to minimize potential side effects.
Sukinsa 25mg Capsule may cause skin lightening and hair loss. You might also experience dry, thickened, or cracked skin, blisters, or rashes, particularly on your palms and soles. These side effects usually disappear after stopping the medication. However, serious, potentially fatal skin reactions like severe rash or rapidly spreading skin ulcers can occur. Report any signs of skin infection (fever, pain, redness, swelling, pus, or bleeding) to your doctor immediately.
Sukinsa 25mg Capsules can cause life-threatening liver damage. Report itching, jaundice (yellow eyes or skin), dark urine, or right upper abdominal pain or discomfort to your doctor immediately. Your doctor will monitor your liver function with blood tests before and throughout treatment. They may temporarily or permanently discontinue the medication if liver problems develop.
Sukinsa 25mg Capsules have no generic equivalents. They function by inhibiting protein kinase, an enzyme on the surface of cancer cells that drives their growth and spread. This inhibition prevents cancer progression. Other protein kinase inhibitors include erlotinib, gefitinib, lapatinib, vemurafenib, and dasatinib.
Sukinsa 25mg Capsules are not supported by studies for use with other chemotherapy drugs. It's used to treat gastrointestinal stromal tumors (GIST), a cancer affecting the stomach and intestines, specifically when imatinib, another anticancer medication, is ineffective or unsuitable for the patient.
Sukinsa 25mg Capsules can lower blood sugar. Diabetics should monitor their blood sugar closely as it may drop dangerously low, potentially causing unconsciousness. Your anti-diabetic medication dosage may need adjustment based on these readings.
Sukinsa 25mg Capsules may raise blood pressure. Regular blood pressure monitoring is crucial. Report severe headache, dizziness, lightheadedness, or vision changes to your doctor immediately. They may adjust your medication or temporarily suspend treatment until your blood pressure normalizes.
Sukinsa 25mg Capsule
3,160
MRP 3,850
17% off